
Caroline Pearson, executive director of the Peterson Center on Healthcare, explains a new analysis of use and payment for remote monitoring technologies.
Richard Payerchin is editor of Medical Economics.

Caroline Pearson, executive director of the Peterson Center on Healthcare, explains a new analysis of use and payment for remote monitoring technologies.

Caroline Pearson, executive director of the Peterson Center on Healthcare, explains a new analysis of use and payment for remote monitoring technologies.

Caroline Pearson, executive director of the Peterson Center on Healthcare, explains a new analysis of use and payment for remote monitoring technologies.

Caroline Pearson, executive director of the Peterson Center on Healthcare, explains a new analysis of use and payment for remote monitoring technologies.

Food, chemicals, behavior, medicine all play a role in helping or hurting Americans’ health, according to new MAHA report, but farmers say there’s junk science behind some claims.

AAFP board chair details potential effects in critique of federal spending plan.

Responses focus on health care as House approves One Big Beautiful Bill federal spending legislation.

HHS has made changes, but lawmakers want prior auth procedures codified in law.

Biden reveals aggressive prostate cancer that has metastasized to his bones.

HHS announces plan to create ‘most-favored-nation’ cost scale so U.S. is not subsidizing drug prices in other countries.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

The former president likely will have drug therapy to lower his testosterone levels, but there are other treatment options.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.

Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.

Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.

Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.

Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

House Budget Committee takes up debate and AMGA publishes projections due to Medicaid cuts in One Big Beautiful Bill Act.

Trump administration tallies ‘staggering cost’ of opioid epidemic as lawmakers ponder budget.

Congressional committees review spending with Health and Human Services Department leader.

Public health experts react to HHS Secretary Robert F. Kennedy’s testimony of budget in House of Representatives.

Robert F. Kennedy Jr. testifies about HHS budget before House Appropriations Committee.